MedTrace Logo

KONECT RESILIA Aortic Valved Conduit (AVC) Real-world Study Assessing Safety and Performance

NCT07619872 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2026-07-17

No results posted yet for this study

Summary

KONECTION is a prospective, observational, single-arm, multicenter study designed to collect real-world clinical outcomes in up to 250 participants who will receive the KONECT RESILIA aortic valved conduit, Model 11060A.

Conditions

  • Aortic Valve Disease

Interventions

DEVICE

Edwards KONECT RESILIA AVC

Surgical replacement of the aortic valve and ascending aorta with the Edwards KONECT RESILIA AVC

Sponsors & Collaborators

  • Edwards Lifesciences

    lead INDUSTRY

Principal Investigators

  • Markus Krane, Prof. Dr. med. · TUM Universitätsklinikum Deutsches Herzzentrum

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-25
Primary Completion
2028-12-31
Completion
2039-06-30
FDA Device
Yes

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07619872 on ClinicalTrials.gov